OLIGMED
OLIGMED
Oligmed is a technology-intensive bio-startup developing advanced ingredients for FSMP and nutraceuticals based on industry-academia-research collaboration. Since 2025, we have focused on addressing critical health challenges including appetite regulation, muscle vitality, pain management, and cognitive care through science-based natural solutions.
Innovators creating results through specialized expertise.
Associate Professor, Dept. of Physiology
KHU College of Korean Medicine
MD (Korean Medicine), Ph.D.
Research Professor
Dept. of Physiology, KHU
Research Assistant
Dept. of Physiology, KHU
Ph.D Candidate, KHU
M.E., KAIST (Innovation & Technology Mgmt.)
MD (Korean Medicine)
Oligmed provides optimized targeted nutritional solutions addressing appetite decline, nutrient absorption, and muscle loss.
OLIM-01 is a bioenhancer that, when taken orally, helps prevent appetite and weight loss while enhancing the absorption of amino acids and peptides.
Developed using AI-based network pharmacology screening to identify key Korean traditional herbal ingredients effective for enhancing muscle strength.
Key achievements and ongoing global projects.
Oligmed, led by CEO Woojin Kim, received the Excellence Award from the Preliminary Startup Package program organized by KISED under the Ministry of SMEs and Startups.
Oligmed won the Grand Prize at the startup pitch competition hosted by Kyung Hee University Technology Holdings.
Supported by KHUBI (Kyung Hee Univ. Business Incubator). CEO Kim introduces our vision and solutions for anorexia based on natural product research.
Watch on YouTube →
Strategic meeting with a French joint research team to discuss new material development and commercialization, aiming to secure global competitiveness.
Discussing entry into 'Station F', the world's largest startup campus in Paris, and participating in local product exhibitions to showcase Oligmed's technology.
Signed an MOU with Miraculus for RWE (Real-World Evidence) based verification to secure scientific evidence for product efficacy and safety.
Discussed product promotion with an influencer (760k followers) influential in Korea and Southeast Asia, strengthening brand awareness in the region.
Media coverage of Oligmed’s research and commercialization activities.
At the 1st Pyeongchang Green Bio Night forum, Oligmed CEO Woojin Kim presented a field case on radish seed–based product development. The event brought companies, universities, and research institutes together to expand the green bio industry network.
Read the article →
Exclusive technology protected by patents and trademarks.
No. 40-2025-0165152
Jeung-Saeng-Dam
No. 10-2025-0125012
Method for producing steamed ginger & Poria cocos extract for improving nutrient absorption